Literature DB >> 24872132

Weight as predictors of clinical progression and treatment failure: results from the TREAT Asia Pediatric HIV Observational Database.

Azar Kariminia1, Nicolas Durier, Gonzague Jourdain, Suneeta Saghayam, Chau V Do, Lam Van Nguyen, Rawiwan Hansudewechakul, Pagakrong Lumbiganon, Kulkanya Chokephaibulkit, Khanh Huu Truong, Virat Sirisanthana, Vibol Ung, Saphonn Vonthanak, Jintanat Ananworanich, Nik Khairulddin Nik Yusoff, Nia Kurniati, Kamarul Azahar Razali, Moy Siew Fong, Revathy Nallusamy, Dewi Kumara Wati.   

Abstract

OBJECTIVE: To evaluate the value of time-updated weight and height in predicting clinical progression, and immunological and virological failure in children receiving combination antiretroviral therapy (cART).
METHODS: We used Cox regression to analyze data of a cohort of Asian children.
RESULTS: A total of 2608 children were included; median age at cART was 5.7 years. Time-updated weight for age z score < -3 was associated with mortality (P < 0.001) independent of CD4% and < -2 was associated with immunological failure (P ≤ 0.03) independent of age at cART.
CONCLUSIONS: Weight monitoring provides useful data to inform clinical management of children on cART in resource-limited settings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24872132      PMCID: PMC4134392          DOI: 10.1097/QAI.0000000000000227

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  24 in total

1.  British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.

Authors:  A Pozniak; B Gazzard; J Anderson; A Babiker; D Churchill; S Collins; M Fisher; M Johnson; S Khoo; C Leen; C Loveday; G Moyle; M Nelson; B Peter; A Phillips; D Pillay; E Wilkins; I Williams; M Youle
Journal:  HIV Med       Date:  2003-10       Impact factor: 3.180

2.  Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up.

Authors:  Mary Munyagwa; Kathy Baisley; Jonathan Levin; Michael Brian; Heiner Grosskurth; Dermot Maher
Journal:  Trop Med Int Health       Date:  2012-05-16       Impact factor: 2.622

3.  Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Authors:  Gwenda Verweel; Annemarie M C van Rossum; Nico G Hartwig; Tom F W Wolfs; Henriëtte J Scherpbier; Ronald de Groot
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

4.  Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Authors:  J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo
Journal:  Ann Intern Med       Date:  1997-06-15       Impact factor: 25.391

5.  Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine. AIDS Clinical Trials Group Protocol 043 Study Group.

Authors:  R E McKinney; C Wilfert
Journal:  J Pediatr       Date:  1994-11       Impact factor: 4.406

6.  Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy.

Authors:  Sharon A Nachman; Jane C Lindsey; Stephen Pelton; Lynne Mofenson; Kenneth McIntosh; Andrew Wiznia; Kenneth Stanley; Ram Yogev
Journal:  Arch Pediatr Adolesc Med       Date:  2002-05

7.  2000 CDC Growth Charts for the United States: methods and development.

Authors:  Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Vital Health Stat 11       Date:  2002-05

8.  Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children.

Authors:  K Buchacz; J S Cervia; J C Lindsey; M D Hughes; G R Seage; W M Dankner; J M Oleske; J Moye
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

9.  Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.

Authors:  Philippa M Musoke; Peter Mudiope; Linda N Barlow-Mosha; Patrick Ajuna; Danstan Bagenda; Michael M Mubiru; Thorkild Tylleskar; Mary G Fowler
Journal:  BMC Pediatr       Date:  2010-08-06       Impact factor: 2.125

10.  A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV.

Authors:  Daniel K Benjamin; Wiliam C Miller; Daniel K Benjamin; Robert W Ryder; David J Weber; Emmanuel Walter; Ross E McKinney
Journal:  AIDS       Date:  2003-11-07       Impact factor: 4.177

View more
  4 in total

1.  Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy.

Authors:  Tavitiya Sudjaritruk; Linda Aurpibul; Penh Sun Ly; Thoa Phan Kim Le; Torsak Bunupuradah; Rawiwan Hansudewechakul; Pagakrong Lumbiganon; Kulkanya Chokephaibulkit; Nik Khairulddin Nik Yusoff; Lam Van Nguyen; Kamarul Azahar Mohd Razali; Moy Siew Fong; Revathy A Nallusamy; Nia Kurniati; Viet Chau Do; David C Boettiger; Annette H Sohn; Azar Kariminia
Journal:  J Adolesc Health       Date:  2017-03-24       Impact factor: 5.012

2.  Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis With Antiretroviral Therapy.

Authors:  David C Boettiger; Dina Muktiarti; Nia Kurniati; Khanh H Truong; Suneeta Saghayam; Penh Sun Ly; Rawiwan Hansudewechakul; Lam Van Nguyen; Viet Chau Do; Tavitiya Sudjaritruk; Pagakrong Lumbiganon; Kulkanya Chokephaibulkit; Torsak Bunupuradah; Nik Khairulddin Nik Yusoff; Dewi Kumara Wati; Kamarul Azahar Mohd Razali; Moy Siew Fong; Revathy A Nallusamy; Annette H Sohn; Azar Kariminia
Journal:  Clin Infect Dis       Date:  2016-07-28       Impact factor: 9.079

3.  Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa.

Authors:  Theresa M Rossouw; Ute D Feucht; George Melikian; Gisela van Dyk; Winifred Thomas; Nicolette M du Plessis; Theunis Avenant
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

4.  Anthropometric Improvement among HIV Infected Pre-School Children Following Initiation of First Line Anti-Retroviral Therapy: Implications for Follow Up.

Authors:  Atnafu Mekonnen Tekleab; Birkneh Tilahun Tadesse; Ababi Zergaw Giref; Damte Shimelis; Meseret Gebre
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.